KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance

Mastrocola, R;Cento, AS;Fornelli, C;Zotta, A;Perrelli, A;Retta, SF
2019-01-01

2019
55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
Barcelona, SPAIN
SEP 16-20, 2019
62
S322
S322
http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=4&SID=D3Lky6GK5JXLcrwXeXd&page=1&doc=1&cacheurlFromRightClick=no
KRIT1; Cerebral Cavernous Malformation (CCM) Disease; Redox Signaling; Sphingolipid Metabolism; Hepatosteatosis; Liver fibrosis; Insulin-Resistance
Mastrocola, R; Cento, AS; Fornelli, C; Zotta, A; Perrelli, A; Retta, SF
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1723192
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact